Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia - PubMed (original) (raw)

Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia

H M Inskip et al. Br J Cancer. 1999 Mar.

Free PMC article

Abstract

Mortality from cancer among 178 parents and 236 grandparents of 95 British patients with ataxia-telangiectasia was examined. For neither parents nor grandparents was mortality from all causes or from cancer appreciably elevated over that of the national population. Among mothers, three deaths from breast cancer gave rise to a standardized mortality ratio of 3.37 (95% confidence interval (CI): 0.69-9.84). In contrast, there was no excess of breast cancer in grandmothers, the standardized mortality ratio being 0.89 (95% CI: 0.18-2.59), based on three deaths. This is the largest study of families of ataxia-telangiectasia patients conducted in Britain but, nonetheless, the study is small and CIs are wide. However, taken together with data from other countries, an increased risk of breast cancer among female heterozygotes is still apparent, though lower than previously thought.

PubMed Disclaimer

Similar articles

• Cancer risks and mortality in heterozygous ATM mutation carriers.
  Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF. Thompson D, et al. J Natl Cancer Inst. 2005 Jun 1;97(11):813-22. doi: 10.1093/jnci/dji141. J Natl Cancer Inst. 2005. PMID: 15928302
• Role of the ataxia-telangiectasia gene (ATM) in breast cancer. A-T heterozygotes seem to have an increased risk but its size is unknown.
  Lavin M. Lavin M. BMJ. 1998 Aug 22;317(7157):486-7. doi: 10.1136/bmj.317.7157.486. BMJ. 1998. PMID: 9712591 Free PMC article. No abstract available.
• Cancer risk in heterozygotes for ataxia-telangiectasia.
  Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N. Geoffroy-Perez B, et al. Int J Cancer. 2001 Jul 15;93(2):288-93. doi: 10.1002/ijc.1329. Int J Cancer. 2001. PMID: 11410879
• The ataxia-telangiectasia gene: a link between checkpoint controls, neurodegeneration and cancer.
  Lehmann AR, Carr AM. Lehmann AR, et al. Trends Genet. 1995 Oct;11(10):375-7. doi: 10.1016/s0168-9525(00)89112-x. Trends Genet. 1995. PMID: 7482757 Review. No abstract available.
• Ataxia-telangiectasia, ATM and genomic stability: maintaining a delicate balance. Two international workshops on ataxia-telangiectasia, related disorders and the ATM protein.
  Shiloh Y. Shiloh Y. Biochim Biophys Acta. 1998 Oct 14;1378(2):R11-8. doi: 10.1016/s0304-419x(98)00020-1. Biochim Biophys Acta. 1998. PMID: 9823376 Review. No abstract available.

Cited by

• Variation of ATM Gene Expression in Peripheral Blood Cells of Sporadic Breast Carcinomas in Iranian Patients.
  Foroughizadeh M, Mozdarani H, Majidzadeh-A K, Kaviani A. Foroughizadeh M, et al. Avicenna J Med Biotechnol. 2012 Apr;4(2):95-101. Avicenna J Med Biotechnol. 2012. PMID: 23408238 Free PMC article.
• Limited MOMP, ATM, and their roles in carcinogenesis and cancer treatment.
  Bao X, Liu X, Li F, Li CY. Bao X, et al. Cell Biosci. 2020 Jun 18;10:81. doi: 10.1186/s13578-020-00442-y. eCollection 2020. Cell Biosci. 2020. PMID: 32566127 Free PMC article. Review.
• The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice.
  Stucci LS, Internò V, Tucci M, Perrone M, Mannavola F, Palmirotta R, Porta C. Stucci LS, et al. Genes (Basel). 2021 May 13;12(5):727. doi: 10.3390/genes12050727. Genes (Basel). 2021. PMID: 34068084 Free PMC article. Review.
• Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
  Umesako S, Fujisawa K, Iiga S, Mori N, Takahashi M, Hong DP, Song CW, Haga S, Imai S, Niwa O, Okumoto M. Umesako S, et al. Breast Cancer Res. 2005;7(1):R164-70. doi: 10.1186/bcr968. Epub 2004 Dec 10. Breast Cancer Res. 2005. PMID: 15642165 Free PMC article.
• A review on role of ATM gene in hereditary transfer of colorectal cancer.
  Sriramulu S, Ramachandran M, Subramanian S, Kannan R, Gopinath M, Sollano J, Bissi L, Banerjee A, Marotta F, Pathak S. Sriramulu S, et al. Acta Biomed. 2019 Jan 15;89(4):463-469. doi: 10.23750/abm.v89i4.6095. Acta Biomed. 2019. PMID: 30657113 Free PMC article. Review.

References

1. 1. N Engl J Med. 1987 May 21;316(21):1289-94 - PubMed
2. 1. Cancer Res. 1988 May 15;48(10):2929-32 - PubMed
3. 1. Genes Chromosomes Cancer. 1990 Nov;2(4):339-40 - PubMed
4. 1. N Engl J Med. 1991 Dec 26;325(26):1831-6 - PubMed
5. 1. N Engl J Med. 1992 May 14;326(20):1357; author reply 1360-1 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal